Alex Blyth

BSc (Econ), BSc (Bio)

Chief Executive Officer (CEO)

Serial entrepreneur with 15 years’ experience in commercialising novel biopharma assets and strategy consulting, having advised teams and led the strategic planning for bringing to market over 50 assets for companies like Pfizer, Allergan, abbVie, Amgen, Shire, Takeda, GSK & Sanofi. Founded the company after losing his mother to Pancreatic Cancer, and seeing a new way to beat cancer by utilising the innate immune system.

Dr John Gonzalez-Carvajal,

MB Chb Medicine, MBA 


Personally raised over £100m in medical ventures. Held various Chairman positions, including Endomag. Former Life Sciences Partner at Alice Ventures from 1999. Former BD lead at PowderJect Pharmaceuticals.

Professor Zheng Cui


Chief Scientific Advisor

Originally discovered innate cancer immunity through a 'super mouse' and went on to develop the original Leukocyte Infusion Therapy technique. World leading expert in Granulocyte based cancer therapies for 20 years. Committed to working with LIfT BioSciences to bring his groundbreaking work to patients.

Dr Vance Naughton


Head of Research

Over ten years experience in medical research and the biopharma industry. PhD in Pharmacology on the innate immune system and stress response mediators. Lectured for MSc Immunology course at Imperial College London. Previously worked with major global biopharma clients from Allergan to Novo Nordisk.

Dr Rebecca Prue


Quality Control & Manufacturing Advisor

(through KCL Partnership)

An experienced cell and gene therapy quality assurance specialist with a unique blend of experience in both Quality Management and Production Management of Investigational Medicinal Products (IMPs), including cell based products. An Immunologist who's PhD was specifically on Neutrophils, with over 15 years within the biomedical field consisting of experience in all aspects of Quality Management of cell and gene therapy products, including for first-in-human use. 

Dr Panteli Theocharous


Chief Medical Advisor

Industry expert and medical expert with more than 25 years of highly successful translational research, clinical, commercial, and international management experience across healthcare, with a focus in Haemato-Oncology. Trained Immunologist with extensive experience in haematopoietic stem cell transplantation and cell therapies. Led the development and launch of several major cancer drugs within Pharma, Biotech and CRO. Former CMO for Cell Therapeutics prior to successful sale.

Disclaimer: The information, documents and graphic depictions (the "Information") published on this Web site are the property of LIfT BioSciences Ltd. LIfT BioSciences assumes no responsibility for errors or omissions in the Information on this website. In no event shall LIfT BioSciences be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of this Web site or the Information. LIfT BioSciences reserves the right to make additions, deletions, or modification to the Information on the Web site at any time without prior notice.

  • CEO's Linked-in
  • CEO's Twitter
  • LIfTBio on Facebook

©2016 LIfT BioSciences Ltd